Safety Study of PLX108-01 in Patients With Solid Tumors

NCT01004861 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: PLX3397

Sponsor

Daiichi Sankyo

Collaborators

[object Object]